心律管理业务注入心通医疗内情:微创系与高瓴赌约大限将至?

华尔街见闻
17 Jul

分拆上市“老玩家”微创医疗(0853.HK)不玩分拆,开始搞起了合并重组。 7月17日,微创医疗宣布计划心律管理业务与子公司心通医疗(2160.HK)合并。 对于此次业务整合的原因,微创医疗称可以建立心脏病产品平台,共享国际营销及销售渠道等。 这一计划目前是不具约束力的建议。 “建议不具约束力,亦不确定建议能否进行或完成。本公司股东及潜在投资者于买卖本公司证券时务请审慎行事。”微创医疗指出。 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10